A Dose Escalation Study of Vorinostat in Combination With Palliative Radiotherapy for Patients With Non-Small Cell Lung Cancer.

Trial Profile

A Dose Escalation Study of Vorinostat in Combination With Palliative Radiotherapy for Patients With Non-Small Cell Lung Cancer.

Completed
Phase of Trial: Phase I

Latest Information Update: 16 Jan 2013

At a glance

  • Drugs Vorinostat (Primary)
  • Indications Non-small cell lung cancer
  • Focus Adverse reactions
  • Most Recent Events

    • 07 Jun 2010 To date, 8 patients have been enrolled, according to a poster presented at the 2010 annual meeting of the American Society of Clinical Oncology (ASCO).
    • 16 May 2009 Status changed from not yet recruiting to recruiting as reported by ClinicalTrials.gov.
    • 16 May 2009 Actual initiation date (May 2009) added as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top